In Hyperthermia Increased ERK and WNT Signaling Suppress Colorectal Cancer Cell Growth

Although neoplastic cells exhibit relatively higher sensitivity to hyperthermia than normal cells, hyperthermia has had variable success as an anti-cancer therapy. This variable outcome might be due to the fact that cancer cells themselves have differential degrees of sensitivity to high temperature...

Full description

Bibliographic Details
Main Authors: Michael Bordonaro, Senji Shirasawa, Darina L. Lazarova
Format: Article
Language:English
Published: MDPI AG 2016-05-01
Series:Cancers
Subjects:
ERK
WNT
Online Access:http://www.mdpi.com/2072-6694/8/5/49
id doaj-e1f3a8c1a33b4ff1a6128e16b1798bb4
record_format Article
spelling doaj-e1f3a8c1a33b4ff1a6128e16b1798bb42020-11-25T00:03:33ZengMDPI AGCancers2072-66942016-05-01854910.3390/cancers8050049cancers8050049In Hyperthermia Increased ERK and WNT Signaling Suppress Colorectal Cancer Cell GrowthMichael Bordonaro0Senji Shirasawa1Darina L. Lazarova2Department of Basic Sciences, The Commonwealth Medical College, Scranton, PA 18509, USADepartment of Cell Biology, Fukuoka University, Fukuoka 814-0180, JapanDepartment of Basic Sciences, The Commonwealth Medical College, Scranton, PA 18509, USAAlthough neoplastic cells exhibit relatively higher sensitivity to hyperthermia than normal cells, hyperthermia has had variable success as an anti-cancer therapy. This variable outcome might be due to the fact that cancer cells themselves have differential degrees of sensitivity to high temperature. We hypothesized that the varying sensitivity of colorectal cancer (CRC) cells to hyperthermia depends upon the differential induction of survival pathways. Screening of such pathways revealed that Extracellular Signal-Regulated Kinase (ERK) signaling is augmented by hyperthermia, and the extent of this modulation correlates with the mutation status of V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS). Through clonal growth assays, apoptotic analyses and transcription reporter assays of CRC cells that differ only in KRAS mutation status we established that mutant KRAS cells are more sensitive to hyperthermia, as they exhibit sustained ERK signaling hyperactivation and increased Wingless/Integrated (WNT)/beta-catenin signaling. We propose that whereas increased levels of WNT and ERK signaling and a positive feedback between the two pathways is a major obstacle in anti-cancer therapy today, under hyperthermia the hyperinduction of the pathways and their positive crosstalk contribute to CRC cell death. Ascertaining the causative association between types of mutations and hyperthermia sensitivity may allow for a mutation profile-guided application of hyperthermia as an anti-cancer therapy. Since KRAS and WNT signaling mutations are prevalent in CRC, our results suggest that hyperthermia-based therapy might benefit a significant number, but not all, CRC patients.http://www.mdpi.com/2072-6694/8/5/49Hyperthermiacolorectal cancerKRASERKWNT
collection DOAJ
language English
format Article
sources DOAJ
author Michael Bordonaro
Senji Shirasawa
Darina L. Lazarova
spellingShingle Michael Bordonaro
Senji Shirasawa
Darina L. Lazarova
In Hyperthermia Increased ERK and WNT Signaling Suppress Colorectal Cancer Cell Growth
Cancers
Hyperthermia
colorectal cancer
KRAS
ERK
WNT
author_facet Michael Bordonaro
Senji Shirasawa
Darina L. Lazarova
author_sort Michael Bordonaro
title In Hyperthermia Increased ERK and WNT Signaling Suppress Colorectal Cancer Cell Growth
title_short In Hyperthermia Increased ERK and WNT Signaling Suppress Colorectal Cancer Cell Growth
title_full In Hyperthermia Increased ERK and WNT Signaling Suppress Colorectal Cancer Cell Growth
title_fullStr In Hyperthermia Increased ERK and WNT Signaling Suppress Colorectal Cancer Cell Growth
title_full_unstemmed In Hyperthermia Increased ERK and WNT Signaling Suppress Colorectal Cancer Cell Growth
title_sort in hyperthermia increased erk and wnt signaling suppress colorectal cancer cell growth
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2016-05-01
description Although neoplastic cells exhibit relatively higher sensitivity to hyperthermia than normal cells, hyperthermia has had variable success as an anti-cancer therapy. This variable outcome might be due to the fact that cancer cells themselves have differential degrees of sensitivity to high temperature. We hypothesized that the varying sensitivity of colorectal cancer (CRC) cells to hyperthermia depends upon the differential induction of survival pathways. Screening of such pathways revealed that Extracellular Signal-Regulated Kinase (ERK) signaling is augmented by hyperthermia, and the extent of this modulation correlates with the mutation status of V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS). Through clonal growth assays, apoptotic analyses and transcription reporter assays of CRC cells that differ only in KRAS mutation status we established that mutant KRAS cells are more sensitive to hyperthermia, as they exhibit sustained ERK signaling hyperactivation and increased Wingless/Integrated (WNT)/beta-catenin signaling. We propose that whereas increased levels of WNT and ERK signaling and a positive feedback between the two pathways is a major obstacle in anti-cancer therapy today, under hyperthermia the hyperinduction of the pathways and their positive crosstalk contribute to CRC cell death. Ascertaining the causative association between types of mutations and hyperthermia sensitivity may allow for a mutation profile-guided application of hyperthermia as an anti-cancer therapy. Since KRAS and WNT signaling mutations are prevalent in CRC, our results suggest that hyperthermia-based therapy might benefit a significant number, but not all, CRC patients.
topic Hyperthermia
colorectal cancer
KRAS
ERK
WNT
url http://www.mdpi.com/2072-6694/8/5/49
work_keys_str_mv AT michaelbordonaro inhyperthermiaincreasederkandwntsignalingsuppresscolorectalcancercellgrowth
AT senjishirasawa inhyperthermiaincreasederkandwntsignalingsuppresscolorectalcancercellgrowth
AT darinallazarova inhyperthermiaincreasederkandwntsignalingsuppresscolorectalcancercellgrowth
_version_ 1725433326514208768